Annual ROE
529.06%
+976.17%+218.33%
December 31, 2022
Summary
- As of February 10, 2025, CTIC annual return on equity is 529.06%, with the most recent change of +976.17% (+218.33%) on December 31, 2022.
- During the last 3 years, CTIC annual ROE has risen by +626.22% (+644.52%).
Performance
CTIC ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly ROE
425.86%
-124.35%-22.60%
March 31, 2023
Summary
- As of February 10, 2025, CTIC quarterly return on equity is 425.86%, with the most recent change of -124.35% (-22.60%) on March 31, 2023.
- Over the past year, CTIC quarterly ROE has increased by +997.24% (+174.53%).
Performance
CTIC Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
CTIC ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +218.3% | +174.5% |
| 3 y3 years | +644.5% | +459.8% |
| 5 y5 years | +328.5% | +704.5% |
CTIC ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -184.5% | -56.2% | -299.3% |
| 5 y | 5-year | at high | -184.5% | -56.2% | -299.3% |
| alltime | all time | -69.6% | -236.8% | -99.6% | -2669.1% |
CTI BioPharma ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | 425.86%(-22.6%) |
| Dec 2022 | 529.06%(-218.3%) | 550.21%(-43.3%) |
| Sep 2022 | - | 971.20%(-214.4%) |
| Jun 2022 | - | -848.64%(+48.5%) |
| Mar 2022 | - | -571.38%(+99.6%) |
| Dec 2021 | -447.11%(+171.6%) | -286.21%(+61.0%) |
| Sep 2021 | - | -177.78%(+30.5%) |
| Jun 2021 | - | -136.18%(-6.0%) |
| Mar 2021 | - | -144.91%(+8.0%) |
| Dec 2020 | -164.64%(+69.5%) | -134.12%(+10.2%) |
| Sep 2020 | - | -121.72%(-0.6%) |
| Jun 2020 | - | -122.45%(+3.5%) |
| Mar 2020 | - | -118.35%(+21.5%) |
| Dec 2019 | -97.16%(+33.4%) | -97.41%(+50.2%) |
| Sep 2019 | - | -64.87%(+0.3%) |
| Jun 2019 | - | -64.69%(+14.1%) |
| Mar 2019 | - | -56.72%(+12.1%) |
| Dec 2018 | -72.84%(-68.5%) | -50.59%(-39.8%) |
| Sep 2018 | - | -84.10%(+1.3%) |
| Jun 2018 | - | -83.01%(+17.8%) |
| Mar 2018 | - | -70.45%(-62.9%) |
| Dec 2017 | -231.53%(+45.5%) | -190.06%(+19.5%) |
| Sep 2017 | - | -159.00%(-28.8%) |
| Jun 2017 | - | -223.18%(-23.9%) |
| Mar 2017 | - | -293.23%(+108.5%) |
| Dec 2016 | -159.17%(-37.5%) | -140.66%(-41.5%) |
| Sep 2016 | - | -240.34%(-23.7%) |
| Jun 2016 | - | -314.86%(-32.1%) |
| Mar 2016 | - | -463.88%(-40.6%) |
| Dec 2015 | -254.67%(+18.6%) | -781.57%(-49.9%) |
| Sep 2015 | - | -1561.28%(+141.8%) |
| Jun 2015 | - | -645.81%(+57.9%) |
| Mar 2015 | - | -409.08%(+23.7%) |
| Dec 2014 | -214.81%(+100.3%) | -330.82%(+62.1%) |
| Sep 2014 | - | -204.07%(-44.1%) |
| Jun 2014 | - | -364.75%(+29.9%) |
| Mar 2014 | - | -280.87%(+34.0%) |
| Dec 2013 | -107.23%(-70.1%) | -209.67%(-72.0%) |
| Sep 2013 | - | -748.78%(-34.6%) |
| Jun 2013 | - | -1144.60%(-6.1%) |
| Mar 2013 | - | -1218.79%(+11.6%) |
| Dec 2012 | -358.64%(-50.4%) | -1091.83%(-33.4%) |
| Sep 2012 | - | -1638.62%(+42.2%) |
| Jun 2012 | - | -1152.34%(+127.9%) |
| Mar 2012 | - | -505.53%(-32.4%) |
| Dec 2011 | -723.64%(-141.6%) | -747.88%(-70.6%) |
| Sep 2011 | - | -2547.60%(-76.7%) |
| Jun 2011 | - | -10.94 K%(-111.3%) |
| Mar 2011 | - | 96.43 K%(+4301.3%) |
| Dec 2010 | 1741.30%(+238.9%) | 2190.93%(+75.3%) |
| Sep 2010 | - | 1249.58%(-3.0%) |
| Jun 2010 | - | 1288.44%(+192.5%) |
| Mar 2010 | - | 440.55%(+134.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2009 | 513.87%(+277.0%) | 187.52%(+39.8%) |
| Sep 2009 | - | 134.10%(+25.9%) |
| Jun 2009 | - | 106.48%(-12.5%) |
| Mar 2009 | - | 121.68%(-13.2%) |
| Dec 2008 | 136.32%(+6.5%) | 140.14%(-4.3%) |
| Sep 2008 | - | 146.50%(-4.4%) |
| Jun 2008 | - | 153.24%(+13.2%) |
| Mar 2008 | - | 135.43%(+6.9%) |
| Dec 2007 | 128.01%(-4.2%) | 126.64%(+1.6%) |
| Sep 2007 | - | 124.64%(+8.5%) |
| Jun 2007 | - | 114.92%(+5.1%) |
| Mar 2007 | - | 109.34%(-20.9%) |
| Dec 2006 | 133.67%(+39.7%) | 138.20%(+13.9%) |
| Sep 2006 | - | 121.29%(+41.1%) |
| Jun 2006 | - | 85.98%(-5.2%) |
| Mar 2006 | - | 90.66%(+14.9%) |
| Dec 2005 | 95.71%(-73.2%) | 78.89%(-25.1%) |
| Sep 2005 | - | 105.39%(-34.9%) |
| Jun 2005 | - | 161.85%(-22.3%) |
| Mar 2005 | - | 208.27%(-55.2%) |
| Dec 2004 | 356.82%(+126.5%) | 465.26%(+8.4%) |
| Sep 2004 | - | 429.17%(-1.0%) |
| Jun 2004 | - | 433.52%(-19.2%) |
| Mar 2004 | - | 536.75%(+37.7%) |
| Dec 2003 | 157.53%(-341.5%) | 389.84%(-105.4%) |
| Sep 2003 | - | -7157.33%(+2154.6%) |
| Jun 2003 | - | -317.46%(+122.8%) |
| Mar 2003 | - | -142.51%(+68.9%) |
| Dec 2002 | -65.22%(+16.2%) | -84.40%(-42.3%) |
| Sep 2002 | - | -146.33%(+48.2%) |
| Jun 2002 | - | -98.75%(+37.3%) |
| Mar 2002 | - | -71.92%(+31.1%) |
| Dec 2001 | -56.14%(+0.5%) | -54.84%(+38.9%) |
| Sep 2001 | - | -39.48%(+2.4%) |
| Jun 2001 | - | -38.54%(-4.9%) |
| Mar 2001 | - | -40.54%(-23.4%) |
| Dec 2000 | -55.86%(-56.4%) | -52.95%(-22.1%) |
| Sep 2000 | - | -67.96%(-42.1%) |
| Jun 2000 | - | -117.40%(-4.7%) |
| Mar 2000 | - | -123.19%(-1.9%) |
| Dec 1999 | -128.04%(+204.7%) | -125.60%(+32.9%) |
| Sep 1999 | - | -94.54%(+38.5%) |
| Jun 1999 | - | -68.28%(+35.9%) |
| Mar 1999 | - | -50.24%(+20.7%) |
| Dec 1998 | -42.02%(-54.8%) | -41.63%(-1.3%) |
| Sep 1998 | - | -42.18%(+3.5%) |
| Jun 1998 | - | -40.77%(-0.9%) |
| Mar 1998 | - | -41.14%(-1.1%) |
| Dec 1997 | -92.93%(+100.6%) | -41.61%(+39.9%) |
| Sep 1997 | - | -29.74%(+46.9%) |
| Jun 1997 | - | -20.25%(+96.4%) |
| Mar 1997 | - | -10.31% |
| Dec 1996 | -46.33% | - |
FAQ
- What is CTI BioPharma annual return on equity?
- What is the all time high annual ROE for CTI BioPharma?
- What is CTI BioPharma annual ROE year-on-year change?
- What is CTI BioPharma quarterly return on equity?
- What is the all time high quarterly ROE for CTI BioPharma?
- What is CTI BioPharma quarterly ROE year-on-year change?
What is CTI BioPharma annual return on equity?
The current annual ROE of CTIC is 529.06%
What is the all time high annual ROE for CTI BioPharma?
CTI BioPharma all-time high annual return on equity is 1741.30%
What is CTI BioPharma annual ROE year-on-year change?
Over the past year, CTIC annual return on equity has changed by +976.17% (+218.33%)
What is CTI BioPharma quarterly return on equity?
The current quarterly ROE of CTIC is 425.86%
What is the all time high quarterly ROE for CTI BioPharma?
CTI BioPharma all-time high quarterly return on equity is 96.43 K%
What is CTI BioPharma quarterly ROE year-on-year change?
Over the past year, CTIC quarterly return on equity has changed by +997.24% (+174.53%)